Treatment of patients with metastatic pancreatic and gastrointestinal tumours with the somatostatin analogue Sandostatin: a phase II study including endocrine effects.

Somatostatin analogues can suppress the secretion of some gastrointestinal hormones and growth factors involved in the growth regulation of gastrointestinal cancers and can inhibit the growth of experimental pancreatic tumours. Therefore, in a phase II study 34 patients with metastatic pancreatic (n...

Celý popis

Uloženo v:
Podrobná bibliografie
Hlavní autoři: Klijn, J. G., Hoff, A. M., Planting, A. S., Verweij, J., Kok, T., Lamberts, S. W., Portengen, H., Foekens, J. A.
Médium: Artigo
Jazyk:Inglês
Vydáno: Nature Publishing Group 1990
Témata:
Research Article
On-line přístup:https://ncbi.nlm.nih.gov/pmc/articles/PMC1971491/
https://ncbi.nlm.nih.gov/pubmed/1977468
Tagy: Přidat tag
Žádné tagy, Buďte první, kdo otaguje tento záznam!

Podobné jednotky